60 Degrees Pharmaceuticals, Inc.
USD1.80
+0.02 (+1.12%)
CEO
Geoffrey Stuart Dow
IPO Date
2023-07-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.79
Prev. Close
$1.78
Day Low
$1.75
Day High
$1.80
52W Low
$1.22
52W High
$10.77
Market Cap
$0.00B
Volume
0.03M
| -0.4 |
| 31 Dec 2023 | FY | -87.1% | -1485.1% | -77.3% | -48.4% | 0.04 | 2.55 | -64.4 |
| 31 Dec 2022 | FY | -93.7% | -2769.5% | 26.2% | -476.5% | -0.95 | 0.05 | -262.6 |
| 31 Dec 2021 | FY | 26.7% | -366.4% | 24.2% | -305.1% | -1.07 | 1.85 | -381.8 |
| 31 Dec 2020 | FY | 67.8% | -139.1% | 17.3% | -116.4% | -1.09 | 1.70 | -535.2 |
| -0.2 |
| 30 Sept 2025 | Q3 | -22.9% | -529.5% | -52.3% | -34.6% | 0.03 | 2.87 | -0.6 |
| 30 Jun 2025 | Q2 | 50.4% | -1717.7% | -71.4% | -41.5% | 0.06 | 2.27 | -0.5 |
| 31 Mar 2025 | Q1 | 55.2% | -1147.4% | -45.7% | -31.4% | 0.04 | 3.13 | -0.3 |
| 31 Dec 2024 | Q4 | 54.8% | -783.6% | -50.8% | -35.6% | 0.04 | 3.25 | -0.4 |
| 30 Sept 2024 | Q3 | 17.4% | -1596.4% | -35.8% | -29.1% | 0.03 | 5.26 | -1.8 |
| 30 Jun 2024 | Q2 | 28.3% | -3339.0% | -137.5% | -96.4% | 0.05 | 3.09 | -0.9 |
| 31 Mar 2024 | Q1 | 38.1% | 407.4% | 6.0% | 5.1% | 0.02 | 7.16 | 1.6 |
| 31 Dec 2023 | Q4 | -242.5% | -4585.0% | -40.2% | -25.2% | 0.04 | 2.55 | -45.4 |